SORT: The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT01295021
Collaborator
(none)
1,514
99
12
15.3
1.3

Study Details

Study Description

Brief Summary

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    MC MD

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1514 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.
    Study Start Date :
    Feb 1, 2011
    Actual Primary Completion Date :
    Feb 1, 2012
    Actual Study Completion Date :
    Feb 1, 2012

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of SO in newly diagnosed hypertensive patients [Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion.]

    Secondary Outcome Measures

    1. Association of SO and heart rate. [Visits 1-3]

    2. Subjective symptoms noticed by the doctor. [1st visit]

    3. To record the drugs used in the treatment of patients diagnosed with hypertension. [Visits 1-3]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Newly diagnosed essential hypertension patients will be eligible for the study.

    • Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg

    Exclusion Criteria:
    • History of coronary artery disease

    • History of diabetes

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Research Site Agartala India
    2 Research Site Agra India
    3 Research Site Ahmedabad India
    4 Research Site Aligarh India
    5 Research Site Ambattur India
    6 Research Site Amritsar India
    7 Research Site Aurangabad India
    8 Research Site Bangalore India
    9 Research Site Barelly India
    10 Research Site Baroda India
    11 Research Site Batanagar India
    12 Research Site Beed India
    13 Research Site Belgaum India
    14 Research Site Bhagal India
    15 Research Site Bhongi India
    16 Research Site Bhopal India
    17 Research Site Bhuj India
    18 Research Site Burdwan India
    19 Research Site Chandigarh India
    20 Research Site Chennai India
    21 Research Site Chomv India
    22 Research Site Coimbatore India
    23 Research Site Davangere India
    24 Research Site Delhi India
    25 Research Site Dhule India
    26 Research Site Dombivli India
    27 Research Site Ellisbridge India
    28 Research Site Fariadad India
    29 Research Site Faridabad India
    30 Research Site Gandhinagar India
    31 Research Site Ghatkopar East India
    32 Research Site Ghaziabad India
    33 Research Site Gulbarga India
    34 Research Site Guntur India
    35 Research Site Gurgaon India
    36 Research Site Gwalior India
    37 Research Site Hanamkonda India
    38 Research Site Hooghly India
    39 Research Site Hubli India
    40 Research Site Hyderabad India
    41 Research Site Hyd India
    42 Research Site Indore India
    43 Research Site Jabalpur India
    44 Research Site Jaipur India
    45 Research Site Jalandhar India
    46 Research Site Jalgoon India
    47 Research Site Kakinada India
    48 Research Site Kanpur India
    49 Research Site Karad India
    50 Research Site Karimnagar India
    51 Research Site Kolhapur India
    52 Research Site Kolkata- India
    53 Research Site Kolkata India
    54 Research Site Kulhapu India
    55 Research Site Kumta India
    56 Research Site Lucknow India
    57 Research Site Ludhiana India
    58 Research Site Madhyamgram India
    59 Research Site Madurai India
    60 Research Site Miroj India
    61 Research Site Mohali India
    62 Research Site Mozda India
    63 Research Site Mrit Home India
    64 Research Site Mulund India
    65 Research Site Mumbai India
    66 Research Site Murshidabad India
    67 Research Site Nadiad India
    68 Research Site Nagpur India
    69 Research Site Nasik India
    70 Research Site Naugloi India
    71 Research Site Navi Mumbai India
    72 Research Site Nesul India
    73 Research Site New Delhi India
    74 Research Site New Panvel India
    75 Research Site Newdelhi India
    76 Research Site Nipani India
    77 Research Site Op Inchapur India
    78 Research Site Palanpur India
    79 Research Site Panvel. India
    80 Research Site Parganas (Wb) India
    81 Research Site Pune India
    82 Research Site Raipur India
    83 Research Site Rajkot India
    84 Research Site Sahibabad,Gzb India
    85 Research Site Secenderabad India
    86 Research Site Shakar Pur India
    87 Research Site Shimoga India
    88 Research Site Sonarpur India
    89 Research Site Sowcarpet India
    90 Research Site Surat India
    91 Research Site Thane India
    92 Research Site Tirupati India
    93 Research Site Ulhasnagar India
    94 Research Site Vadodara India
    95 Research Site Vijayawada India
    96 Research Site Virar India
    97 Research Site Visakhapatnam India
    98 Research Site Vizag India
    99 Research Site Warangal India

    Sponsors and Collaborators

    • AstraZeneca

    Investigators

    • Principal Investigator: Dr T.N.C. Padmanabhan, Dr. Padmanabhan Heart Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    AstraZeneca
    ClinicalTrials.gov Identifier:
    NCT01295021
    Other Study ID Numbers:
    • NIS-CIN-DUM-2010/2
    First Posted:
    Feb 14, 2011
    Last Update Posted:
    Jun 10, 2013
    Last Verified:
    Jun 1, 2013
    Keywords provided by AstraZeneca
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 10, 2013